Keyphrases
Core Outcome Set
74%
Chronic Kidney Disease
74%
Clinical Trials
59%
Drug Development
43%
Pertuzumab
37%
Reporting Guidelines
37%
Cuban
37%
Urology
37%
Cost-plus
37%
Risk Outcomes
37%
Patient Outcomes
37%
Risk-benefit
37%
Patient Benefit
37%
Randomized Controlled Trial
37%
Web-based Survey
37%
Drug Companies
37%
Clinical Perspective
37%
Medicare
37%
Medicaid
37%
Patient Risk
37%
Clinical Trial Registry
32%
Breast Cancer
21%
Potential Savings
18%
Instructions to Authors
15%
Health Care Costs
12%
Objective Response Rate
12%
Health Research
10%
Descriptive Statistics
9%
International Consortium
9%
Health Measurement
9%
Adverse Events
9%
Health-related Quality of Life
9%
Health Outcomes
9%
Overall Survival
9%
Off-label Use
9%
Trialists
8%
Disease Research
8%
Shipping Cost
6%
Online Pharmacies
6%
Pricing Model
6%
Medicaid Spending
6%
Company Website
6%
Spending Data
6%
Preventative Medicine
6%
Unit Price
6%
Potential Cost Savings
6%
Promoting Sustainability
6%
Long-term Care
6%
Profit Margin
6%
Dispensing Fees
6%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Chronic Kidney Failure
74%
Cross Sectional Study
74%
Drug Development
74%
Pertuzumab
37%
Randomized Controlled Trial
37%
Fluticasone Propionate
37%
Drug Analysis
37%
Atopic Dermatitis
37%
Prescription Drug
37%
Breast Cancer
21%
Overall Survival
12%
Adverse Event
9%
Off-Label Use
9%
Clinical Research
6%
Disease
5%
Medicine and Dentistry
Clinical Trial
94%
Chronic Kidney Disease
74%
Cross Sectional Study
40%
Urology
37%
Pertuzumab
37%
Health Care Cost
37%
Randomized Controlled Trial
37%
Medicare
37%
Breast Cancer
21%
Overall Survival
12%
Health Outcomes
10%
Quality of Life
10%
Adverse Event
9%
Off-Label Use
9%
Kidney Allograft
5%
Protocol Compliance
5%
Clinical Research
5%
Transplantation
5%
Disease
5%
